ProCE Banner Activity

Expert Guidance for the Treatment of CLL: An International Perspective

Tool

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with CLL with those of 5 renowned international experts, from Clinical Care Options.

Released: February 08, 2024

Share

Faculty

Florence Cymbalista

Florence Cymbalista, MD, PhD

Professor of Hematology
Sorbonne Paris Nord University
Bobigny, France

Toby A. Eyre

Toby A. Eyre, MBChB, MD

Hematology Consultant at Oxford University Hospitals
Senior Lecturer at the University of Oxford
Oxford, United Kingdom

Carsten U. Niemann

Carsten U. Niemann, MD, PhD

Associate Professor, Chief Physician
Rigshospitalet, University of Copenhagen
Department of Hematology and Department of Clinical Medicine
Copenhagen, Denmark

Stephan Stilgenbauer

Stephan Stilgenbauer, MD

Medical Director, Comprehensive Cancer Center Ulm
Head, Early Clinical Trials Unit
Head, Division of CLL
Department of Internal Medicine III
Comprehensive Cancer Center Ulm
University Medical Center Ulm
Ulm, Germany

Alessandra Tedeschi

Alessandra Tedeschi, MD

Consultant in Hematology
Department of Hematology
ASST GOM Niguarda
Milano, Italy

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Disclosure

Primary Author

Florence Cymbalista, MD, PhD

Professor of Hematology
Sorbonne Paris Nord University
Bobigny, France

Florence Cymbalista, MD, PhD: consultant/advisor/speaker: AbbVie, AstraZeneca, Beigene, Janssen, Lilly.

Toby A. Eyre, MBChB, MD

Hematology Consultant at Oxford University Hospitals
Senior Lecturer at the University of Oxford
Oxford, United Kingdom

Toby Eyre, MBCHB, MD: consultant/advisor/speaker: AbbVie, AstraZeneca, Autolus, Beigene, Incyte, Janssen, Kite/Gilead, Lilly, Roche, Secura Bio; researcher: AstraZeneca, Beigene.

Carsten U. Niemann, MD, PhD

Associate Professor, Chief Physician
Rigshospitalet, University of Copenhagen
Department of Hematology and Department of Clinical Medicine
Copenhagen, Denmark

Carsten U. Niemann, MD, PhD: consultant/advisor/speaker: AbbVie, AstraZeneca, Behring, Beigene, CSL, Genmab, Janssen, Lilly, MSD, Octapharma, Takeda. 

Stephan Stilgenbauer, MD

Medical Director, Comprehensive Cancer Center Ulm
Head, Early Clinical Trials Unit
Head, Division of CLL
Department of Internal Medicine III
Comprehensive Cancer Center Ulm
University Medical Center Ulm
Ulm, Germany

Stephan Stilgenbauer, MD: consultant/advisor/speaker: AbbVie, Acerta, Amgen, AstraZeneca, BeiGene, Bristol-Myers Squibb, Celgene, Gilead, GlaxoSmithKline, Hoffmann-La Roche, Infinity, Janssen, Novartis, Sunesis, Verastem; research support: AbbVie, Acerta, Amgen, AstraZeneca, BeiGene, Bristol-Myers Squibb, Celgene, Gilead, GlaxoSmithKline, Hoffmann-La Roche, Infinity, Janssen, Novartis, Sunesis, Verastem. 

Alessandra Tedeschi, MD

Consultant in Hematology
Department of Hematology
ASST GOM Niguarda
Milano, Italy

Alessandra Tedeschi, MD: consultant/advisor/speaker: AbbVie, AstraZeneca, Beigene, Janssen, Lilly.